Effect of Leptin on Renal Ischemia-reperfusion Damage in Rats
Overview
Physiology
Affiliations
Tumor necrosis factor-alpha (TNF-alpha) has been established as an important mediator in renal ischemia-reperfusion (I/R) injury. Leptin, a product of the ob gene, has been known to exhibit cytoprotective effects on renal tissue, but its effect on renal tissue TNF-alpha level after renal I/R injury in rats remains unknown. The purpose of the study was to evaluate the effects of leptin on renal tissue TNF-alpha, malondialdehyde (MDA), protein carbonyls (PCs) and total sulfydryl group (SH) levels, and plasma nitrite levels after renal I/R injury in rats. The animals were divided into three groups: control, I/R and I/R+leptin. Rats were subjected to renal ischemia by clamping the left pedicle for 45 min, and then reperfused for 1 h. The I/R+leptin group was pretreated intraperitoneally with leptin (10 microg/kg) 30 min before the induction of ischemia. Our results indicate that MDA, TNF-alpha levels, and PCs were significantly higher in the I/R group than those in the control group (p < 0.05). The administration of leptin decreased these parameters (p < 0.05) significantly. The SH level was observed to significantly decrease after I/R injury when compared to the control group (p < 0.05). Leptin treatment significantly increased tissue SH and plasma nitrite levels when compared to the I/R group (p < 0.05). Plasma nitrite levels did not change significantly in I/R when compared to the control. These results suggest that leptin could exert a protective effect on I/R induced renal damage by decreasing TNF-alpha levels and increasing nitrite level.
Does Ambroxol alleviate kidney ischemia-reperfusion injury in rats?.
Gultekin C, Sayiner S, Cetinel S, Ozer Sehirli A Iran J Basic Med Sci. 2022; 25(8):1037-1041.
PMID: 36159324 PMC: 9464333. DOI: 10.22038/IJBMS.2022.64330.14148.
Ortona S, Barisione C, Ferrari P, Palombo D, Pratesi G J Clin Med. 2022; 11(13).
PMID: 35806921 PMC: 9267902. DOI: 10.3390/jcm11133638.
Netrebenko A, Gureev V, Pokrovskii M, Gureeva A, Tsuverkalova Y, Rozhkov I Arch Razi Inst. 2022; 76(4):995-1004.
PMID: 35096335 PMC: 8791007. DOI: 10.22092/ari.2021.355849.1728.
Soytas M, Gursoy D, Boz M, Cakici C, Keskin I, Yigitbasi T Urol Ann. 2021; 13(4):378-383.
PMID: 34759650 PMC: 8525476. DOI: 10.4103/UA.UA_79_20.
Zhao Y, Ding Z, Ge W, Liu J, Xu X, Cheng R Front Pharmacol. 2021; 12:745425.
PMID: 34721034 PMC: 8548467. DOI: 10.3389/fphar.2021.745425.